Neoadjuvant Chemoimmunotherapy in Patients With Early-Stage NSCLC
A systematic review and meta-analysis found that neoadjuvant chemoimmunotherapy was associated with improved event-free survival and pathologic complete response compared with neoadjuvant chemotherapy…